ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison

被引：18
|
作者：
Myllynen, Paivi [1 ]
Kummu, Maria [1 ,2 ]
Sieppi, Elina [1 ]
机构：
[1] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland
[2] Univ Oulu, Ctr Arctic Med, Thule Inst, FIN-90014 Oulu, Finland
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2010年 / 6卷 / 11期
关键词：
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN EXPRESSION; LIMITS FETAL DISTRIBUTION; MULTIDRUG-RESISTANCE; PHOSPHOGLYCOPROTEIN ABCB1; DRUG TRANSPORTERS; GENE-EXPRESSION; MOUSE PLACENTA; RAT PLACENTA; BCRP/ABCG2;
D O I：
10.1517/17425255.2010.514264
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Areas covered in this review: Comprehensive literature searches were done using PubMed (until June 2010) to identify publications on ABCB1 and ABCG2 expression in placenta and fetal tissues in human, mouse, rat, guinea-pig and rabbit. What the reader will gain: In this review, we aim to provide an overview of the current knowledge on the ABCB1 and ABCG2 transporter expression profiles in the placenta and fetal tissues in humans relative to other species. Take home message: The available information on ABCB1 and ABCG2 temporal expression profiles in placenta and fetus indicates rather good correlation among human, mouse and rat although some specific differences have been reported. However, at this point no detailed comparisons or comparative functional data are available. Detailed knowledge on the expression patterns and functional activity of ABCB1 and ABCG2 transporters placenta and developing embryo/fetus in different species could possibly help the interspecies extrapolation.
引用
收藏
页码：1385 / 1398
页数：14
相关论文
共 50 条
  • [41] Identification of putative steroid-binding sites in human ABCB1 and ABCG2
    Mares-Samano, Sergio
    Badhan, Raj
    Penny, Jeffrey
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (09) : 3601 - 3611
  • [42] Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance
    Sundeep Singh Nimisha
    Abhay Kumar Saluja
    Phani Kumar Sharma
    Arun Nekarakanti
    Real Sumayya Abdul Apurva
    Hasib Kumar
    Vineeta Vijay Sattar
    Syed Akhtar Anjum
    Molecular and Cellular Biochemistry, 2023, 478 : 2379 - 2394
  • [43] Aurones as Modulators of ABCG2 and ABCB1: Synthesis and Structure-Activity Relationships
    Sim, Hong May
    Loh, Ker Yun
    Yeo, Wee Kiang
    Lee, Chong Yew
    Go, Mei Lin
    CHEMMEDCHEM, 2011, 6 (04) : 713 - 724
  • [44] Regulations of ABCB1 and ABCG2 Expression Through MAPK Pathways in Acute Lymphoblastic Leukemia Cell Lines
    Tomiyasu, Hirotaka
    Watanabe, Manabu
    Sugita, Kanji
    Goto-Koshino, Yuko
    Fujino, Yasuhito
    Ohno, Koichi
    Sugano, Sumio
    Tsujimoto, Hajime
    ANTICANCER RESEARCH, 2013, 33 (12) : 5317 - 5323
  • [45] Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells
    Kosztyu, Petr
    Bukvova, Romana
    Dolezel, Petr
    Mlejnek, Petr
    CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 219 : 203 - 210
  • [46] Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates
    Laurent-Olivier Roy
    Myriam Lemelin
    Marie Blanchette
    Marie-Belle Poirier
    Salman Aldakhil
    David Fortin
    Journal of Neuro-Oncology, 2022, 160 : 601 - 609
  • [47] OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation
    Wang, Yaogeng
    Sparidans, Rolf W.
    Li, Wenlong
    Lebre, Maria C.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (13) : 3060 - 3074
  • [48] ABCG2 and ABCB1 efflux drug transporter expression andsingle nucleotide variations (SNVs) in patients on tamoxifen therapy
    Wong, Michelle
    Medwid, Samantha
    Kim, Richard
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2024, 102 (10)
  • [49] Mobocertinib restores the efficacy of cytotoxic drugs in cancer cells overexpressing ABCB1 or ABCG2
    Li, Yenching
    Wu, Chungpu
    CANCER SCIENCE, 2024, 115 : 317 - 317
  • [50] Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma
    Guo, Yuan-yuan
    Wu, Yuan
    Jia, Xiao-wei
    An, Wei
    LABORATORY INVESTIGATION, 2017, 97 (12) : 1400 - 1411
12345